TCR2 Therapeutics Inc. buy quelbe60
Start price
16.10.22
/
50%
€1.68
Target price
16.10.23
-
Performance (%)
-6.83%
End price
30.10.22
€1.56
Summary
This prediction ended on 30.10.22 with a price of €1.56. With a performance of -6.83%, the BUY prediction for TCR2 Therapeutics Inc. by quelbe60 closed slightly in the red. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TCR2 Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to quelbe60 what are the pros and cons of TCR2 Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by quelbe60 for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy TCR2 Therapeutics Inc.